Latest Insider Transactions at Innov Age Holding Corp. (INNV)
This section provides a real-time view of insider transactions for Innov Age Holding Corp. (INNV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of InnovAge Holding Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of InnovAge Holding Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,660
-0.71%
|
$9,960
$6.54 P/Share
|
|
Sep 17
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,521
-3.12%
|
$45,126
$6.0 P/Share
|
|
Sep 16
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,372
-1.78%
|
$21,860
$5.95 P/Share
|
|
Sep 05
2024
|
John Ellis Bush Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+50.0%
|
-
|
|
Sep 05
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+50.0%
|
-
|
|
Sep 05
2024
|
Edward Moore Kennedy Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+31.65%
|
-
|
|
Sep 05
2024
|
Marilyn B Tavenner Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,841
+50.0%
|
-
|
|
Sep 03
2024
|
James G Carlson Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,495
+23.48%
|
-
|
|
Sep 03
2024
|
Patricia Fontneau Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,523
+37.96%
|
-
|
|
Sep 03
2024
|
Teresa Sparks Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,448
+32.73%
|
-
|
|
Sep 01
2024
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,053
-0.81%
|
$30,318
$6.36 P/Share
|
|
Aug 15
2024
|
Richard Feifer CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,303
-6.08%
|
$85,818
$6.22 P/Share
|
|
Aug 15
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
14,303
-5.51%
|
$85,818
$6.22 P/Share
|
|
Jul 02
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,486
-2.8%
|
$37,430
$5.03 P/Share
|
|
Jun 06
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,056
-2.93%
|
$32,224
$4.83 P/Share
|
|
Jun 06
2024
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,088
-1.6%
|
$40,352
$4.83 P/Share
|
|
Jun 06
2024
|
Christine Bent CHIEF OPERATIONS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,187
-4.8%
|
$40,748
$4.83 P/Share
|
|
Jun 06
2024
|
Richard Feifer CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,023
-3.3%
|
$32,092
$4.83 P/Share
|
|
Jun 05
2024
|
Patrick T Blair PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
123,967
+16.42%
|
-
|
|
Jun 04
2024
|
Christine Bent CHIEF OPERATIONS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
86,581
+28.98%
|
-
|
|
Jun 04
2024
|
Nicole Damato CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
97,403
+26.15%
|
-
|
|
Jun 04
2024
|
Richard Feifer CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
108,226
+30.79%
|
-
|
|
Jun 01
2024
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,321
-0.65%
|
$13,284
$4.44 P/Share
|
|
Apr 17
2024
|
Christine Bent CHIEF OPERATIONS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,734
-6.5%
|
$34,936
$4.0 P/Share
|
|
Mar 01
2024
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,566
-0.69%
|
$14,264
$4.87 P/Share
|
|
Feb 22
2024
|
Tco Group Holdings, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,532,542
-3.03%
|
-
|
|
Feb 22
2024
|
Ignite Aggregator LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,532,542
-3.03%
|
-
|
|
Feb 22
2024
|
Welsh, Carson, Anderson & Stowe Xii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,532,542
-3.03%
|
-
|
|
Dec 01
2023
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,322
-0.64%
|
$16,610
$5.9 P/Share
|
|
Sep 01
2023
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,743
-0.91%
|
$23,715
$5.57 P/Share
|
|
Aug 30
2023
|
Patrick T Blair PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,264
+16.78%
|
-
|
|
Aug 15
2023
|
Richard Feifer CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,737
-6.73%
|
$48,685
$5.6 P/Share
|
|
Aug 15
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,673
-5.16%
|
$48,365
$5.6 P/Share
|
|
Aug 14
2023
|
Teresa Sparks Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,362
+50.0%
|
-
|
|
Jul 18
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-2.09%
|
$28,000
$7.12 P/Share
|
|
Jul 17
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,866
-0.97%
|
$13,062
$7.07 P/Share
|
|
Jul 13
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,448
-1.75%
|
$24,136
$7.07 P/Share
|
|
Jul 12
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
411
-0.21%
|
$2,877
$7.08 P/Share
|
|
Jul 11
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
892
-0.45%
|
$6,244
$7.06 P/Share
|
|
Jul 10
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,422
-3.14%
|
$44,954
$7.1 P/Share
|
|
Jul 06
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
139
-0.07%
|
$973
$7.01 P/Share
|
|
Jul 05
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,173
-2.0%
|
$29,211
$7.28 P/Share
|
|
Jul 03
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,101
-1.0%
|
$14,707
$7.26 P/Share
|
|
Jul 02
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
20,220
-8.76%
|
$141,540
$7.5 P/Share
|
|
Jun 06
2023
|
Christine Bent CHIEF OPERATIONS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,152
+27.97%
|
-
|
|
Jun 06
2023
|
Richard Feifer CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,152
+26.49%
|
-
|
|
Jun 06
2023
|
Nicole Damato CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,152
+18.42%
|
-
|
|
Jun 01
2023
|
Patrick T Blair PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,321
-0.79%
|
$19,926
$6.73 P/Share
|
|
Apr 17
2023
|
Christine Bent CHIEF OPERATIONS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
82,143
+50.0%
|
-
|
|
Apr 17
2023
|
Patricia Fontneau Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,286
+50.0%
|
-
|